Carrie may not be going back to Texas after all... at least not immediately. She emailed her doctor at MD Anderson today since she had not heard anything since last week. Shortly thereafter, she received a phone call from the trial coordinator and was given some new developments with the new clinical trial Carrie was going to participate it. Apparently, the drug company sponsoring the trial has decided to increase the dosage of the medication (for whatever reason, which we don't know), as well as change a few things, such as different tests they want to run and the amount of blood they would draw. As a result, all of these changes have to be approved by some board and these changes usually take at least a month to be approved, if not longer. That being said, there is no way of knowing when Carrie would be able to start this trial. She still has a spot in the trial and once the changes are approved, she would be able to start. Her doctor, however, is concerned about Carrie possibly going for an indeterminable amount of time without ANY type of treatment in the meantime. And unfortunately, Carrie's doctor doesn't know of any other current trials that she could participate in. He suggested Carrie get in contact with her oncologist from UAB and see if there were any other options there.
So it seems we really are back to square one. We were optimistic about this new trial, but we are concerned about going without treatment for what could turn out to be weeks or even months. The only other option would be to start taking the Mitotane again. Carrie emailed her doctor at UAB this afternoon and will hopefully hear back from her early next week. Until then, we're just going to pray something opens up and we can get back on track. We will update everyone as soon as we hear something.
No comments:
Post a Comment